A 24-year-old man showed thyrotoxic symptoms with hypokalemic periodic paralysis. Serum thyroid hormone levels were high and thyrotropin (TSH) was undetectable. 123I-thyroidal uptake was suppressed. TSH-binding inhibitor immunoglobulin (TBII) was positive. After a month without any treatment, he became hypothyroid. Thyroid hormone level was decreased and TSHwas increased to above the normal range. 123I-thyroidal uptake was increased. TBII activity was still positive. From the clinical findings, a diagnosis of silent thyroiditis was made. Sera obtained in the hypothyroid state revealed the presence of thyroid-stimulationblocking antibodies (TSBAb), but there were no thyroid-stimulating antibodies (TSAb). These results suggest that the hypothyroidism in this patient was due to the presence of TSBAbwith TBII activity.
characterized by transient thyrotoxicosis , non-tender thyroid gland, and low radioactive iodine uptake (1 , 2) . Among the patients with silent thyroiditis 30-40% develop transient hypothyroidism after transient thyrotoxicosis (1, 2) . Permanent hypothyroidism may occur (3). However, the mechanism(s) which causes transient or permanent hypothyroidism remains unknown. Here, we report a patient with silent thyroiditis whose hypothyroidism might be due to the presence of thyroid-stimulation-blocking antibodies (TSBAb) in the serum (4, 5), as measured by inhibition of the thyrotropin (TSH)-induced CAMP increase using porcine thyroid cells.
CASE REPORT
A 24-year-old man was referred to Gifu Red Cross Hospital on June 3, 1988 for further evaluation of thyroid status. He had been in good health until April 1988, when he noticed finger tremor. On April 25, he had severe muscle weakness in the lower extremities and could not walk for a while. From that time, a similar episode occurred one or two times each week. In the morning of May19, he was admitted to Owase General Hospital because of flaccid paralysis of the legs and arms. Serum potassium was 2.8 mmol/1. The paralysis was readily resolved by potassium chloride administration.
Serum potassium level on the following day was 4.8 mmol/1. His thyroid was enlarged. Serum levels of triiodothyronine (T3), thyroxine (T4), and TSH were From the clinical course and laboratory findings, a diagnosis of silent thyroiditis was made.
DISCUSSION
The patient showed transient hyperthyroidism followed by hypothyroidism.
The first time 123I-thyroidal uptake was tested, free thyroid hormones decreased rapidly and TSH increased from an undetectable level to the normal range as shown in Table 1 . Therefore, 123I-uptake in this patient was not as suppressed as that in patients with silent thyroiditis in the thyrotoxic phase (1, 2). It is generally thought that silent thyroiditis is a variant of Hashimoto's thyroiditis (1, 2). In the present study, the microscopic findings of thyroid tissue did not show the typical features of Hashimoto's thyroiditis such as follicular destruction, oxyphilic cell changes, and fibrosis. Concerning this point, Inada et al (9) and Mizukami et al (10) reported that the histological abnormalities, such as lymphocytic infiltration and follicular destruction, can improve spontaneously in the late recovery phase. The present histological findings were in agreement with those of their reports, although our patient was still in the hypothyroid state. From the thyroid histology, it is suggested that his thyroid function could improve if TSBAbactivity would decrease or disappear in the future (ll).
This patient was first thought to have Graves' disease with periodic paralysis. However, the clinical course and changes in thyroid functions were compatible with the diagnosis of silent thyroiditis, although TBII was strongly positive throughout the study. In 1975, Gluck et al (12) reported a 24-yearold male with silent thyroiditis who had an acute episode of hypokalemic paralysis. Since then, several similar cases have been reported (13) (14) (15) . These reports suggest that high levels of thyroid hormones alone could play an important role in the develop- The presence of TSBAbhas been demonstrated in patients with Graves' disease who became hypothyroid after antithyroid drug treatment (1 8). Miyauchi et al (19) reported a 35-year-old man with Graves' disease who had both TSAband TSBAbin serum at first presentation. TSBAbincreased and TSAbdisappeared when he became hypothyroid after antithyroid drug treatment. Later, TSAbreappeared and TSBAb decreased when hyperthyroidism recurred. These reports suggest that thyroid function may vary depending on the balance between TSAband TSBAbactivities in the affected patients with anti-TSH receptor antibody. However, we considered that our patient's hyperthyroid state was induced mainly by the destruction of the thyroid gland, and not by the presence of TSAb, since 123I-thyroidal uptake obtained just before the hypothyroid phase was not elevated and was even lower than that obtained during the hypothyroid phase.
However, the involvement of TSAb cannot be totally disregarded.
123I-thyroidal uptake has been reported to be low in patients with primary hypothyroidism with TSBAb(20) and in patients with Graves' disease who developed hypothyroidism due to the appearance of TSBAb (18) . In contrast to these reports, 123I-uptake was normal when the patient was hypothyroid. Miyauchi et al (19) also reported a normal 13^-uptake in a hypothyroid patient with TSBAb during treatment with 1-T4. Therefore, TSBAb in these patients may mainly inhibit a post-process of TSH-stimulated iodine uptake in vivo (21). In contrast to the reports of Yamamoto et al (16) and Smallridge et al (22) 
